A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer
NCT ID: NCT05990478
Last Updated: 2025-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2023-08-03
2024-07-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion
NCT05036083
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
NCT06220214
Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery
NCT03070340
Biennial CEM in Women With a Personal History of Breast Cancer
NCT06105749
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
NCT05206331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with Breast Cancer
Participants will have a diagnosis of breast cancer
Contrast-Enhanced Mammography
Participants will have pre- and post-treatment CEM of the affected breast
Breast MRI
Pre- and post-NAT breast MRI will be performed for all participants
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Contrast-Enhanced Mammography
Participants will have pre- and post-treatment CEM of the affected breast
Breast MRI
Pre- and post-NAT breast MRI will be performed for all participants
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with breast cancer and schedule for NAT
Exclusion Criteria
* Known allergic reaction to gadolinium or iodinated contrast media.
* Contraindication to contrast-enhanced breast MRI.
* Lesion not included in the field of view of either pre- or post-NAT MRI or CEM
* Presence of pacemakers or automated implantable cardioverter defibrilator
* Pregnant women
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joao Machado Horvat, MD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-224
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.